@stargate334 This is just the outlook for FY18, coming off a higher base post the Conject acquisition, which saw a 143% increase in European revenue in FY17. Medium to long term outlook is 20% plus, compounding revenue growth.
Both the plus part and the compounding part are important. Constantly compounding revenue increases, especially in the double digits, are pretty powerful. They tend to double the top line pretty quickly.
Next results are due 20th Feb 18. They will be of great interest, especially the FCF and EBITDA growth.
------------------------------------------------------------------------------------------------------------- This post is based on my own research and is not investment advice. When making investment decisions, always DYOR.
ACX Price at posting:
$4.84 Sentiment: Buy Disclosure: Held